JPMorgan downgraded Kazatomprom to Neutral from Overweight with a price target of $42, up from $34. Following the stock’s recent rally, Kazatomprom’s valuation gap has closed and its risk/reward profile is fairly balanced, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
